Investment in New Capability for Materials Analysis
News Aug 07, 2014
This world class site is close to both Oxford University and Johnson Matthey’s Sonning Common Research laboratories and is home to Diamond, the UK’s synchrotron science facility, where currently 24 experimental stations (beamlines) are operational with funding in place to increase this number to 33 by 2018.
As part of Diamond’s pioneering hard X-ray nanoprobe beamline (I14) and electron microscopy centre, Johnson Matthey and Oxford University will each contribute cutting-edge microscopes from JEOL to support research in the Physical Sciences. These microscopes will complement two other advanced electron microscopes that will also be built at the new centre as part of a National Facility for Cryo-Electron Microscopy. Overall, the new centre will offer unrivalled facilities for research across the biological and physical sciences.
The hard X-ray nanoprobe will take structural analysis with detailed element mapping to the highest spatial X-ray resolution available anywhere in the world. Oxford University will bring a unique JEOL 300kV electron microscope dedicated to atomic scale imaging at world-leading resolution and Johnson Matthey will install a world-leading JEOL double-EDX and EELS capable microscope dedicated to chemical analysis with atomic scale resolution. Collaborations between Johnson Matthey, Oxford University and Diamond’s I14 beamline will facilitate the interchange of samples between these systems and enable analyses at near-duty catalytic conditions to observe the influence of chemical and thermal challenges on material structure.
Commenting on this development: Dr Elizabeth Rowsell (Director, Johnson Matthey Technology Centre) said “This is an exciting development for Johnson Matthey research, we chose to bring our investment to Diamond’s I14 beamline to further strengthen our extensive collaborations in advanced characterisation”; Professor Angus Kirkland (Oxford University) said “This facility will provide a world class capability for materials imaging and our collaboration with Johnson Matthey will bring real problems into focus and pose new questions.
The combination of the 2 electron microscopes with the Nanoprobe will deliver unique insights and Diamond will provide the best possible environment to enable scientific interaction”; Professor Andrew Hamilton, (Vice-Chancellor of Oxford University), said: “Bringing together these powerful instruments in one place will be hugely beneficial to researchers, both in academia and industry, who are studying materials at the atomic scale. This new facility could lead to advances in many exciting research areas including graphene technology and the development of cleaner, greener fuels.”
Professor Andrew Harrison (CEO Diamond Light Source) said “We welcome closer engagement with UK companies such as JM. This development is part of a more general trend to develop strategic partnerships with industry and university, often underpinned by investment in complementary equipment or people, to exploit more fully our synchrotron facilities”;
Mr. Koichi Fukuyama (Director JEOL Europe) said “This is a wonderful opportunity for JEOL and we are excited to be supporting the advanced characterisation research facilities that are being planned for the benefit of both academic and industrial scientists from the UK and beyond.”
Building Molecular Wires, One Atom at a TimeNews
Electronic devices are getting smaller and smaller. Early computers filled entire rooms. Today you can hold one in the palm of your hand. Now the field of molecular electronics is taking miniaturization to the next level. Researchers are creating electronic components so tiny they can’t be seen with the naked eye.READ MORE
Longevity Protein Reveals its SecretsNews
In a recent study, researchers revealed the three-dimensional structure of a proteins linked to longevity and metabolism, beta-Klotho, illuminating its intricate mechanism and therapeutic potential. The study findings could have implications for therapies developed to treat a wide range of medical conditions, including diabetes, obesity, and certain cancers.READ MORE
Multidisciplinary Study Suggests New Strategy for Drug DiscoveryNews
A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.READ MORE